Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Rachel E J,Besser ^[1] ; Anna E,Long ^[2] ; Katharine R,Owen ^[3] ; Rebecca,Law ^[4] ; Jacqueline S,Birks ^[5] ; Olivia,Pearce ^[2] ; Claire L,Williams ^[6] ; Claire L,Scudder ^[3] ; Timothy J,McDonald ^[3] ; John A,Todd ^[1]

作者单位： Juvenile Diabetes Research Foundation/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Oxford National Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford, Oxford, U.K. ^[1] Department of Paediatric Diabetes, Oxford Children's Hospital, John Radcliffe Hospital, Oxford, U.K. ^[2] Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K. ^[3] Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, U.K. ^[4] Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K. ^[5] Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Centre for Statistics in Medicine, University of Oxford, Oxford, U.K. ^[6] Academic Department of Blood Sciences, Royal Devon University Hospital, Exeter, U.K. ^[7] Exeter NIHR Biomedical Research Centre, University of Exeter, Exeter, U.K. ^[8]